Close

Spectrum Pharma (SPPI) Misses Q4 EPS by 4c

March 6, 2018 4:00 PM EST

Spectrum Pharma (NASDAQ: SPPI) reported Q4 EPS of ($0.29), $0.04 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $28.6 million versus the consensus estimate of $32.93 million.

For earnings history and earnings-related data on Spectrum Pharma (SPPI) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings